Company news

Insulet Corporation news in 2025

Insulet Corporation's news releases, calls and decks from 2025, newest first.

View company

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

December 15, 2025

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

December 14, 2025

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

December 3, 2025

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

November 19, 2025

Insulet Reports Third Quarter 2025 Results

November 5, 2025

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

October 29, 2025

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 22, 2025

Insulet to Host Investor Day on November 20, 2025

October 9, 2025

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

September 17, 2025

Insulet Announces CFO Transition

September 15, 2025

Insulet Elevates Eric Benjamin to Chief Operating Officer

August 24, 2025

Insulet to Participate in Upcoming Investor Conferences

August 18, 2025

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

August 7, 2025

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency¹)

August 6, 2025

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

July 7, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

June 18, 2025

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

June 9, 2025

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 22, 2025

Insulet Announces Publication of 2024 Sustainability Report

May 12, 2025

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 8, 2025

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency¹)

May 7, 2025

Insulet Appoints Ashley McEvoy President and CEO

April 27, 2025

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

April 7, 2025

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

April 2, 2025

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

March 18, 2025

Insulet Expands Omnipod® 5 to Four More International Markets

March 17, 2025

Insulet Announces Proposed Financing Transactions

March 17, 2025

Insulet Announces Pricing of Senior Notes Due 2033

March 17, 2025

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

March 17, 2025

Insulet to Host Investor Day on June 5, 2025

March 10, 2025

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

February 19, 2025

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

January 12, 2025

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

January 9, 2025

Calls in 2025

Decks in 2025